[复发性乳腺癌与骨转移有效治疗阿贝马西克利布加内分泌疗法-一个病例报告]
Keita Adachi1, Junko Nagae, Hitomi Kubota
1Dept. of Surgery, The Nippon Dental University School of Life Dentistry.
Gan to kagaku ryoho. Cancer & chemotherapy
|February 2, 2024
概括
一名患有复发性乳腺癌和骨转移的绝经前妇女在接受abemaciclib和内分泌治疗后经历了完全缓解. 这种组合疗法在治疗绝经前患者转移性乳腺癌方面表现出显著的有效性.
科学领域:
- 在瘤学瘤学.
- 医疗 治疗 医疗 治疗
背景情况:
- 一名46岁的绝经前妇女有IIIC阶段侵袭性右乳腺导管癌的病史,接受了乳房切除,化疗,照射和他莫西芬的治疗.
- 乳腺癌与骨转移的复发是在初始治疗6年后被诊断出来的.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.7K
相关概念视频
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
